A new study from researchers at the University of Michigan Comprehensive Cancer Center sheds light on the KRAS pathway with a potential target that might have more success at stopping lung cancer growth.
News and Events
Recent Releases01/27/2015 - 2:00pm01/22/2015 - 3:45pm
Researchers at the University of Michigan Comprehensive Cancer Center have received a grant from the Lustgarten Foundation worth $1.5 million for a project focused on using a pancreatic cancer patient's blood sample to determine the best treatments.01/19/2015 - 11:00am
Researchers at the University of Michigan Comprehensive Cancer Center analyzed the global landscape of a portion of the genome that has not been previously well-explored. This analysis opens the door to discovery of thousands of potential new cancer biomarkers.01/15/2015 - 9:15am
New research helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.01/15/2015 - 9:00am
A new study characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors.